|
Dec 3
|
AstraZeneca ties up with AI biologics company to develop cancer drug
|
|
Dec 1
|
Directors’ Deals: Strategy refresh spurs Unilever directors
|
|
Dec 1
|
AstraZeneca (AZN) to Discontinue Two Studies on Lokelma
|
|
Nov 30
|
Presage Biosciences Announces New Pharma Partnership to Evaluate Novel Immuno-Oncology Drug Combinations with CIVO® Technology
|
|
Nov 29
|
17 Best European Countries to Move to from the USA
|
|
Nov 29
|
AstraZeneca advances scientific leadership in hematology at ASH 2023
|
|
Nov 28
|
15 Hardest Countries to Get Citizenship in Europe
|
|
Nov 28
|
UPDATE 2-White House urges RSV immunization makers to meet demand
|
|
Nov 28
|
30 Countries with the Highest Quality of Life Heading into 2024
|
|
Nov 27
|
Tesla sues Sweden in bid to avoid hit from strikes
|
|
Nov 27
|
Theseus (THRX) Up 57% in a Month on Strategic Restructuring Plan
|
|
Nov 27
|
Do AstraZeneca's (LON:AZN) Earnings Warrant Your Attention?
|
|
Nov 26
|
12 Best Diabetes Stocks To Buy Now
|
|
Nov 26
|
15 Best Drug Stocks To Invest In
|
|
Nov 9
|
The battle for weight loss drug dominance is heating up. Here's why.
|
|
Nov 9
|
Petrol garages under fire over rising margins at the pump
|
|
Nov 9
|
AstraZeneca bets on weight-loss pill to compete with wave of new ‘miracle’ jabs
|
|
Nov 9
|
AstraZeneca enters weight-loss market with oral GLP-1 drug
|
|
Nov 9
|
AstraZeneca Is Making A $2 Billion Bet To Rival Lilly, Novo In Obesity Drugs
|
|
Nov 9
|
AstraZeneca Strikes a Deal for an Experimental Weight-Loss Drug and Boosts Its Guidance
|